Literature DB >> 3299096

Insulin resistance in essential hypertension.

E Ferrannini, G Buzzigoli, R Bonadonna, M A Giorico, M Oleggini, L Graziadei, R Pedrinelli, L Brandi, S Bevilacqua.   

Abstract

High blood pressure is prevalent in obesity and in diabetes, both conditions with insulin resistance. To test whether hypertension is associated with insulin resistance independently of obesity and glucose intolerance, we measured insulin sensitivity (using the euglycemic insulin-clamp technique), glucose turnover (using [3H]glucose isotope dilution), and whole-body glucose oxidation (using indirect calorimetry) in 13 young subjects (38 +/- 2 years [+/- SEM]) with untreated essential hypertension (165 +/- 6/112 +/- 3 mm Hg), normal body weight, and normal glucose tolerance. In the postabsorptive state, all measures of glucose metabolism were normal. During steady-state euglycemic hyperinsulinemia (about 60 microU per milliliter), hepatic glucose production and lipolysis were effectively suppressed, and glucose oxidation and potassium disposal were normally stimulated. However, total insulin-induced glucose uptake was markedly impaired (3.80 +/- 0.32 vs. 6.31 +/- 0.42 mg per minute per kilogram of body weight in 11 age- and weight-matched controls, P less than 0.001). Thus, reduced nonoxidative glucose disposal (glycogen synthesis and glycolysis) accounted for virtually all the defect in overall glucose uptake (1.19 +/- 0.24 vs. 3.34 +/- 0.44 mg per minute per kilogram, P less than 0.001). Total glucose uptake was inversely related to systolic or mean blood pressure (r = 0.76 for both, P less than 0.001). These results provide preliminary evidence that essential hypertension is an insulin-resistant state. We conclude that this insulin resistance involves glucose but not lipid or potassium metabolism, is located in peripheral tissues but not the liver, is limited to nonoxidative pathways of intracellular glucose disposal, and is directly correlated with the severity of hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299096     DOI: 10.1056/NEJM198708063170605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  299 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Sex-related differences in the insulin resistance syndrome.

Authors:  D B Corry
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

3.  Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic response to adrenaline infusions in normal subjects.

Authors:  O Hansen; B W Johansson
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

4.  Hyperinsulinaemia and blood pressure in patients with insulinoma.

Authors:  N Fujita; T Baba; T Tomiyama; T Kodama; N Kako
Journal:  BMJ       Date:  1992-05-02

5.  The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

Authors:  C Berne; J Fagius; T Pollare; P Hjemdahl
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

6.  The Jamaican hypertension prevalence study.

Authors:  Dalip Ragoobirsingh; Donovan McGrowder; Errol Y Morrison; Pauline Johnson; Eva Lewis-Fuller; John Fray
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

Review 7.  Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.

Authors:  Henry A Punzi; Connie F Punzi
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

Review 8.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 9.  Angiotensin and insulin resistance: conspiracy theory.

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 10.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.